share_log

Silver Bullet Mines Corp. Provides Update on The Buckeye Mine High Grade Gold, Platinum, and Palladium and Provides First Stage Check of Initial Assays Results

Silver Bullet Mines Corp. Provides Update on The Buckeye Mine High Grade Gold, Platinum, and Palladium and Provides First Stage Check of Initial Assays Results

Silver Bullet Mines Corp. 提供七叶树矿高品位金、铂金和钯金的最新情况,并对初步化验结果进行第一阶段检查
newsfile ·  2023/03/02 15:11

Burlington, Ontario--(Newsfile Corp. - March 2, 2023) - Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) ('SBMI' or 'the Company'). Based on a review of the Company's technical disclosure by staff of the Ontario Securities Commission the Company is issuing the following update.

安大略省伯灵顿-(Newsfile Corp.-2023年3月2日)-银弹矿业公司(多伦多证券交易所股票代码:SBMI)(场外交易市场代码:SBMCF)(以下简称:SBMI或公司)。根据安大略省证券委员会工作人员对该公司技术披露的审查,该公司发布以下更新。

On September 26, 2022 and October 18, 2022 the Company disclosed high-grade gold, platinum, palladium, rhodium, and osmium (the "Bonus Materials") results from the Buckeye Mine from the in initial lab.

2022年9月26日和2022年10月18日,该公司披露了七叶树矿在初始实验室中的高品位金、铂、钯、铑和Os(“红利材料”)结果。

The Company has subsequently received results on or about January 17, 2023 from six referee/check samples submitted to another independent third-party lab (Activation Laboratories Inc. (Actlabs)) which puts these previously released assay results into question. These new results indicate an absence of gold, palladium, and platinum. Please see the table below.

该公司随后在2023年1月17日左右收到了提交给另一家独立第三方实验室(Activation实验室Inc.(Actlabs))的6份推荐人/检查样本的结果,这对之前公布的这些测试结果提出了质疑。这些新的结果表明,金、钯和铂是不存在的。请见下表。

Assay Results
Actlabs Certificate No. Initial Lab (ppb) Actlabs (ppb)
Sample No. Initial Lab Actlabs Au Pd Pt Au Pd Pt
I342175 2210001-11 A22-18646 22900 10400 61 2 < 5 < 5
I342176 2210001-10 A22-18646 30600 13600 70 3 < 5 < 5
I342177 2210001-1 A22-18646 14600 18900 50 4 < 5 5
I342178 2210001-12 A22-18646 81700 15900 93 < 2 < 5 < 5
I342179 2210001-8 A22-18646 31800 16009 93 5 < 5 < 5
I342180 (Duplicate) 2210001-1 A22-18646 14600 18900 172 < 2 < 5 < 5
I342181 (Standard) A22-18646 88 683 581
I342182 (blank) A22-18646 < 2 < 5 < 5
化验结果
Actlabs 证书编号 初始实验(Ppb) Actlabs(Ppb)
样本号 初始实验 Actlabs Au 局部放电 PT Au 局部放电 PT
I342175 2210001-11 A22-18646 22900 10400 61 2
I342176 2210001-10 A22-18646 30600 13600 70 3
I342177 2210001-1 A22-18646 14600 18900 50 4 5
I342178 2210001-12 A22-18646 81700 15900 93
I342179 2210001-8 A22-18646 31800 16009 93 5
I342180(复制) 2210001-1 A22-18646 14600 18900 172
I342181(标准) A22-18646 88 683 581
I342182(空白) A22-18646

Notes:

备注:

1) Standard used for sample I342181 was CDN-PGMS-29 a certified reference material with expected values of Au (88 ppb), Pd (677 ppb), and Pt (550 ppb)
2) Blank used for sample I342182 was barren silica material.

1)样品I342181使用的标准是CDN-PGMS-29,一种经过认证的标准物质,期望值为Au(88 Ppb)、Pd(677 Ppb)和铂(550 Ppb)
2)样品I342182所用空白为无硅材料。

Investors should not rely on the assay results previously reported by the Company on September 26, 2022 and October 18, 2022.

投资者不应依赖本公司此前于2022年9月26日和2022年10月18日报告的化验结果。

In addition, the Company's November 3, 2022 news release indicated that assay results from samples of diabase at several locations near and in the Buckeye Silver Mine were received and were being considered and would be disclosed to the public as soon as possible. Based on six referee/check samples noted above, the Company does not intend to disclose these results as they are considered unreliable at this time.

此外,公司2022年11月3日的新闻稿显示,已收到七叶树银矿附近和几个地点辉绿岩样本的化验结果,并正在考虑中,并将尽快向公众披露。基于上述六个推荐人/支票样本,本公司不打算披露这些结果,因为它们目前被认为是不可靠的。

The Company has engaged and sent samples to another independent certified lab (Third Lab). The Third Lab is performing check assay results using the same analytical method as the initial lab. Such results will be disclosed immediately upon receipt.

该公司已聘请另一家独立认证实验室并将样本送往(第三个实验室)。第三个实验室正在使用与最初实验室相同的分析方法进行检查化验结果。这些结果将在收到后立即披露。

The QAQC set out below is important as Actlabs that completed the check assays followed an analytical process different from the initial lab that produced the data reported by the Company on September 26, 2022 and October 18, 2022.

下面列出的QAQC非常重要,因为完成检查化验的Actlabs遵循了与最初实验室不同的分析程序,最初的实验室产生了公司于2022年9月26日和2022年10月18日报告的数据。

QAQC

QAQC

The Company had retained representative material from which each of the initial lab samples were obtained. A total of 6 samples inclusive of one duplicate were selected by the Company's QP, Robert G. Komarechka P.Geo., from this material and secured in sealed and labeled sample bags and delivered to a local courier in Globe, Arizona who then forwarded the samples on to Actlabs in Thunder Bay. The shipment also included duplicates, standards and blanks. In addition, Actlabs also used its own standards, blanks and duplicates. Actlabs undertook assaying of these 6 samples using ICP (induced coupled plasma) followed by OES (optical emission spectroscopy) analysis. This is a different analytical analysis used by the initial lab which was by MS (mass spectroscopy). SBMI is investigating whether the difference in process could explain the discrepancy in results.

该公司保留了具有代表性的材料,每一份最初的实验室样本都是从这些材料中获得的。该公司的QP Robert G.Komarechka P.Geo从该材料中挑选了6个样品,其中包括一个副本,并将其固定在密封并贴上标签的样品袋中,然后交付给亚利桑那州Globe的一名当地快递员,后者随后将样品转发给桑德贝的Actlabs。这批货物还包括复制品、标准和空白。此外,Actlabs还使用了自己的标准、空白和复制品。Actlabs对这6个样品进行了ICP(诱导耦合等离子体)和OES(光学发射光谱分析)分析。这是最初实验室使用的一种不同的分析方法,即MS(质谱学)。SBMI正在调查过程中的差异是否可以解释结果的差异。

Mr. Robert G. Komarechka, P.Geo., an independent consultant, has reviewed and verified SBMI's work referred to herein, and is the Qualified Person for this release.

独立顾问Robert G.Komarechka,P.Geo已经审查和验证了本文提及的SBMI的工作,是本新闻稿的合格人选。

For further information, please contact:

如需更多信息,请联系:

John Carter
Silver Bullet Mines Corp., CEO
cartera@sympatico.ca
+1 (905) 302-3843

约翰·卡特
银弹矿业公司,首席执行官
邮箱:cartera@sympatico.ca
+1 (905) 302-3843

Peter M. Clausi
Silver Bullet Mines Corp., VP Capital Markets
pclausi@brantcapital.ca
+1 (416) 890-1232

彼得·M·克劳西
资本市场副总裁Silver Bullet Mines Corp.
邮箱:pClausi@brantcapal.ca
+1 (416) 890-1232

Cautionary and Forward-Looking Statements

警告性和前瞻性陈述

This news release contains certain statements that constitute forward-looking statements as they relate to SBMI and its subsidiaries. Forward-looking statements are not historical facts but represent management's current expectation of future events, and can be identified by words such as "believe", "expects", "will", "intends", "plans", "projects", "anticipates", "estimates", "continues" and similar expressions. Although management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that they will prove to be correct.

本新闻稿包含一些与SBMI及其子公司有关的前瞻性陈述。前瞻性陈述不是历史事实,而是代表管理层目前对未来事件的预期,可以通过“相信”、“预期”、“将”、“打算”、“计划”、“项目”、“预期”、“估计”、“继续”等词语来识别。尽管管理层认为这些前瞻性陈述中的预期是合理的,但不能保证它们将被证明是正确的。

By their nature, forward-looking statements include assumptions, and are subject to inherent risks and uncertainties that could cause actual future results, conditions, actions or events to differ materially from those in the forward-looking statements. If and when forward-looking statements are set out in this new release, SBMI will also set out the material risk factors or assumptions used to develop the forward-looking statements. Except as expressly required by applicable securities laws, SBMI assumes no obligation to update or revise any forward-looking statements. The future outcomes that relate to forward-looking statements may be influenced by many factors, including but not limited to: the impact of SARS CoV-2 or any other global virus; reliance on key personnel; the thoroughness of its QA/QA procedures; the continuity of the global supply chain for materials for SBMI to use in the production and processing of mineralized material; the presence of mineable economic mineralized material; shareholder and regulatory approvals; activities and attitudes of communities local to the location of the SBMI's properties; risks of future legal proceedings; income tax matters; fires, floods and other natural phenomena; the rate of inflation; availability and terms of financing; distribution of securities; commodities pricing; currency movements, especially as between the USD and CDN; effect of market interest rates on price of securities; and, potential dilution. SARS CoV-2 and other potential global pathogens create risks that at this time are immeasurable and impossible to define.

就其性质而言,前瞻性陈述包括假设,并受内在风险和不确定因素的影响,这些风险和不确定性可能导致未来的实际结果、条件、行动或事件与前瞻性陈述中的结果、条件、行动或事件大不相同。如果在这一新的新闻稿中陈述了前瞻性陈述,SBMI还将陈述用于制定前瞻性陈述的重大风险因素或假设。除非适用的证券法明确要求,否则SBMI不承担更新或修改任何前瞻性陈述的义务。与前瞻性陈述有关的未来结果可能受到许多因素的影响,包括但不限于:SARS CoV-2或任何其他全球病毒的影响;对关键人员的依赖;其质量保证/质量保证程序的彻底性;供SBMI用于矿化材料生产和加工的材料的全球供应链的连续性;是否存在可开采的经济矿化材料;股东和监管机构的批准;SBMI资产所在地社区的活动和态度;未来法律诉讼的风险;所得税问题;火灾、洪水和其他自然现象;通货膨胀率;可获得性和融资条件;证券的分配;商品定价;货币变动,特别是美元和加拿大元之间的汇率变动;市场利率对证券价格的影响;以及潜在的摊薄。SARS CoV-2和其他潜在的全球病原体造成的风险目前是无法衡量和无法定义的。

To view the source version of this press release, please visit

要查看本新闻稿的源版本,请访问

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发